Screener
Amphastar Pharmaceuticals AMPH Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's gross margin?
- Amphastar Pharmaceuticals (AMPH) reported gross margin of 47.7% in Q2 2026.
- How has Amphastar Pharmaceuticals's gross margin changed year-over-year?
- Amphastar Pharmaceuticals's gross margin decreased by 4.4% year-over-year, from 49.9% to 47.7%.
- What is the long-term trend for Amphastar Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's gross margin has grown at a 3.8% compound annual growth rate (CAGR), from 41% to 49.5%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Amphastar Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude